As reported by Wang et al. [39], sodium butyrate has the potential to mitigate hypertension induced by angiotensin II and improves the associated renal injury, encompassing urinary albumin excretion, glomerulosclerosis, and renal fibrosis. Here, ALB is linked to glomerulosclerosis.